20.8 million Medicare enrollees set to get a one-time $90 payment
CMS says 20.8 million people enrolled in Original Medicare Part B are scheduled to receive a one-time $90 payment in October.
CMS says 20.8 million people enrolled in Original Medicare Part B are scheduled to receive a one-time $90 payment in October.
The Trump administration is ending a temporary Medicare Part D subsidy that offset an average of $16 per person in 2026. Beneficiaries could face higher monthly costs in 2027 as plans finalize offerings.
CMS will end a temporary Medicare Part D program after 2026. MedPAC estimated it reduced the average standalone drug-plan premium by $16 in 2026, potentially increasing costs for some enrollees in 2027.
A new CMS demonstration began July 1, 2026, offering eligible Medicare Part D beneficiaries certain GLP-1 medications for $50 per monthly supply through the end of 2027.
CMS proposed long-term rules for negotiating and renegotiating prices for high-cost, single-source Medicare drugs beginning in 2029. Comments are due Aug. 17, 2026.
An interim final rule from CMS will require certain adult Medicaid applicants and enrollees to document 80 hours of work, education, training or community service each month.
The Centers for Medicare & Medicaid Services said it would end a prescription-drug subsidy program created in 2024. The effect on beneficiaries will vary.
Federal health officials paused more than $1 billion in Medicaid payments to California and Minnesota while reviewing high-risk claims, including California in-home-care claims.
The proposed changes would make accountable-care organizations easier to join and shift clinicians away from traditional MIPS reporting. Comments are due Sept. 14, 2026.
A new CMS proposal would amend the indirect hold-harmless threshold for health-care-related taxes and could require states to reassess Medicaid financing arrangements.
Federal health officials said they deferred approximately $867.5 million in Medicaid payments to Minnesota while the state supplies documentation supporting claims identified as high risk.